Nature5 年
False lumen size: a powerful predictor of acute type B aortic dissection
Mortality and morbidity from aortic dissection remain unacceptably high. Early complications carry a high risk of death, and as the anatomy of aortic dissection is usually complex, total aortic ...
Nature5 年
Partial thrombosis of the false lumen independently predicts mortality
Tsai et al. examined data from the International Registry of Acute Aortic Dissection to determine whether partial thrombosis of the false lumen (defined as presence of both flow and thrombus ...
knskashmir10 天
SKIMS Performs Complex Cardiac Surgery
Srinagar, Dec16 (KNS): The Department of Cardiovascular and Thoracic Surgery (CVTS) at SKIMS has successfully performed a ...
Endovascular Today16 天
Artivion Granted FDA Humanitarian Device Exemption for AMDS Hybrid Prosthesis
Artivion, Inc. announced that the FDA has granted a humanitarian device exemption (HDE) for the use of the AMDS hybrid ...
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and Drug Administration (FDA) has granted a Humanitarian ...
The Victoria Advocate17 天
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis
About the AMDS PERSEVERE Clinical Trial The PERSEVERE trial is a prospective, multicenter, non-randomized clinical trial to determine if patients with acute DeBakey Type I aortic dissection can be ...